FDA recall D-0280-2022
Teligent Pharma, Inc. · Class I · drug
Product
Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310, NDC 52565-009-50
Reason for recall
Superpotent Drug
Distribution
Nationwide within the United States
Key facts
- Status
- Terminated
- Initiation date
- 2021-10-12
- Report date
- 2021-12-22
- Termination date
- 2024-06-18
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Buena, NJ, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0280-2022